Evidence map›Paper›PMID 30656629›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

Reference Transcriptome for Deriving Marmoset Induced Pluripotent Stem Cells.

Guang Yang, Hyenjong Hong, April Torres, Kristen E Malloy, Gourav Roy-Choudhury, Jeffrey Kim, Marcel M Daadi

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guang YangSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Hyenjong HongSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
April TorresSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Kristen E MalloySouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Gourav Roy-ChoudhurySouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Jeffrey KimSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Marcel M DaadiSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA. mdaadi@txbiomed.org.

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
NCATS NIH HHS UL1 TR001120NIH HHS P51 OD011133
6 · The paper itself

Abstract

Limited access to primary tissue from various nonhuman primate (NHP) species represents a significant unmet need that hampers progress in understanding unique cellular diversity and gene regulation of specific tissues and organs in stem cell translational research. Most comparative biology studies have been limited to using postmortem tissue usually frozen specimens with limited utility for research. The generation of induced pluripotent stem cell (iPSC) lines from somatic cells, such as adult skin or blood cells, offers an alternative to invasive and ethically controversial interventions for acquiring tissue. Pluripotent iPSCs have virtually an unlimited capacity to proliferate and differentiate into all cell types of the body. We are generating high-quality validated NHP iPSC lines to offer to scientific community and facilitate their research programs. We use the non-integrative episomal vector system to generate iPSCs from NHP skin biopsies. In this chapter we describe the validation of NHP iPSC lines by confirming pluripotency and their propensity to differentiate into all three germ layers ectoderm, mesoderm, and endoderm according to established standards and measurable limits for a set of marker genes incorporated into a scorecard.

Indexed as

Gene Expression ProfilingRegenerative MedicineTranscriptomeAnimalsBiopsyCallithrixCell LineEmbryoid BodiesInduced Pluripotent Stem CellsSkinWorkflowiPSC characterizationMarmoset iPSCsNonhuman primate iPSCsPluripotencyRegenerative medicineScorecard

Identifiers

PMID30656629
PMCPMC6605048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.